196 related articles for article (PubMed ID: 12809173)
1. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.
Oliveira JH; Vieira JG; Abucham J; Lengyel AM
J Endocrinol Invest; 2003 Mar; 26(3):230-5. PubMed ID: 12809173
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
3. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
Arvat E; Ramunni J; Giordano R; Maccagno B; Broglio F; Benso A; Deghenghi R; Ghigo E
J Endocrinol Invest; 1999 Jan; 22(1):23-8. PubMed ID: 10090133
[TBL] [Abstract][Full Text] [Related]
4. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
[TBL] [Abstract][Full Text] [Related]
5. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
[TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa.
Foppiani L; Sessarego P; Valenti S; Falivene MR; Cuttica CM; Giusti Disem M
Eur J Clin Invest; 1996 Oct; 26(10):879-83. PubMed ID: 8911861
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
Coiro V; Volpi R; Capretti L; Caffarri G; Chiodera P
J Intern Med; 2000 Jun; 247(6):667-73. PubMed ID: 10886488
[TBL] [Abstract][Full Text] [Related]
9. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Gianotti L; Broglio F; Benso A; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
11. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
Correa-Silva SR; Nascif SO; Lengyel AM
Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
Leal-Cerro A; Torres E; Soto A; Dios E; Deghenghi R; Arvat E; Ghigo E; Dieguez C; Casanueva FF
Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947
[TBL] [Abstract][Full Text] [Related]
14. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
[TBL] [Abstract][Full Text] [Related]
15. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
Pecori Giraldi F; Invitti C; Cavagnini F;
Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome.
Sakai Y; Horiba N; Tozawa F; Sakai K; Kuwayama A; Demura H; Suda T
Endocr J; 1997 Oct; 44(5):687-95. PubMed ID: 9466324
[TBL] [Abstract][Full Text] [Related]
17. Effect of one month ketoconazole treatment on GH, cortisol and ACTH release after ghrelin, GHRP-6 and GHRH administration in patients with Cushing's disease.
Correa-Silva SR; Nascif SO; Silva MR; Molica P; Lengyel AM
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1110-7. PubMed ID: 18157387
[TBL] [Abstract][Full Text] [Related]
18. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
Pecori Giraldi F; Marini E; Torchiana E; Mortini P; Dubini A; Cavagnini F
J Endocrinol; 2003 Jun; 177(3):373-9. PubMed ID: 12773117
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease.
Losa M; Mortini P; Dylgjeri S; Barzaghi R; Franzin A; Mandelli C; Giovanelli M
Clin Endocrinol (Oxf); 2001 Jul; 55(1):61-8. PubMed ID: 11453953
[TBL] [Abstract][Full Text] [Related]
20. GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.
Martins MR; Pinto AC; Brunner E; Silva MR; Lengyel AM
J Endocrinol Invest; 2003 Feb; 26(2):143-7. PubMed ID: 12739742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
